bcl-2 protein downregulation is not required for differentiation of multidrug resistant HL60 leukemia cells.
暂无分享,去创建一个
A. Fojo | L. Neckers | M. Blagosklonny | M. Alvarez | Leonard M. Neckers | Mikhail V. Blagosklonny | A. T. Fojo | Manuel Alvarez
[1] W. Mercer,et al. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. , 1995, Cancer research.
[2] Z. Su,et al. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. , 1994, Oncogene.
[3] C. Guillouf,et al. Induction of p21 (WAF-1/CIP1) during differentiation. , 1994, Oncogene.
[4] L. Neckers,et al. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[5] T. Takizawa,et al. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. , 1994, Blood.
[6] S. Collins,et al. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. , 1994, Blood.
[7] John Calvin Reed,et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. , 1994, Oncogene.
[8] M. Cleary,et al. Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. , 1994, Blood.
[9] Yi-Song Wang,et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.
[10] L. Neckers,et al. Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines. , 1994, Cancer letters.
[11] John Calvin Reed. Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.
[12] C. Tepper,et al. 1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. , 1993, Experimental cell research.
[13] Z. Oltvai,et al. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. , 1993, Seminars in cancer biology.
[14] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[15] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[16] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.
[17] R. Mohammad,et al. Prothymosin alpha gene expression correlates with proliferation, not differentiation, of HL-60 cells. , 1993, Blood.
[18] R. Glazer,et al. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities. , 1993, Molecular pharmacology.
[19] S. Korsmeyer. Bcl-2 initiates a new category of oncogenes: regulators of cell death. , 1992, Blood.
[20] D. Kufe,et al. Internucleosomal DNA fragmentation during phorbol ester-induced monocytic differentiation and G0/G1 arrest. , 1992, The Journal of clinical investigation.
[21] M. Pierotti,et al. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. , 1992, Blood.
[22] S. Bates,et al. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. , 1990, Biochemistry.
[23] S. Collins,et al. Expression of the beta-subunit of the human leukocyte adherence receptor depends upon cell type and stage of differentiation. , 1988, Journal of Immunology.
[24] K. D. Hartman,et al. Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells. , 1988, Cancer research.
[25] R. Locksley,et al. Expression of leukocyte adherence-related glycoproteins during differentiation of HL-60 promyelocytic leukemia cells. , 1987, Journal of immunology.
[26] V. Rotter,et al. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[27] John Calvin Reed,et al. Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. , 1994, Antisense research and development.